Literature DB >> 16048669

The prevalence and costs of obesity in the EU.

James Fry1, Willa Finley.   

Abstract

The present paper reports on results obtained as part of the economics module of the LIPGENE project. It reviews recent trends in obesity in the fifteen member states of the EU (the member states before enlargement in 2004) and concludes that in 2002 for both adult men and women at least half the fifteen member states of the EU had obesity levels of >20%. In the same year the total direct and indirect annual costs of obesity in the fifteen member states of the EU were 32,800 euro x 10(6). The provision of 'healthy' foods with an adapted lipid profile provides one means of mitigating the impact of obesity. However, there are extra costs associated with the supply of such foods, via additional costs of food ingredients, identity preservation costs for premium-value food products and the penalties caused by the inability to exploit economies of scale. The limited scale of the markets for healthy foods is caused by their high selling prices. Also presented is an analysis of the costs of subsidising, throughout the EU, ingredients that improve the fatty acid profile of beef, eggs, poultry meat and low-fat spreads, so that healthier versions of these products sell at the same price as traditional alternatives. The total costs of such subsidies for these four food products would have been 10 euro x 10(9)/year in 2002, which was 30% of the direct and indirect costs of obesity.

Entities:  

Mesh:

Year:  2005        PMID: 16048669     DOI: 10.1079/pns2005443

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  21 in total

Review 1.  Health-economic burden of obesity in Europe.

Authors:  Falk Müller-Riemenschneider; Thomas Reinhold; Anne Berghöfer; Stefan N Willich
Journal:  Eur J Epidemiol       Date:  2008-05-29       Impact factor: 8.082

2.  Economic evaluation of URMEL-ICE, a school-based overweight prevention programme comprising metabolism, exercise and lifestyle intervention in children.

Authors:  Dorothea Kesztyüs; Anja Schreiber; Tamara Wirt; Martina Wiedom; Jens Dreyhaupt; Susanne Brandstetter; Benjamin Koch; Olivia Wartha; Rainer Muche; Martin Wabitsch; Reinhold Kilian; Jürgen M Steinacker
Journal:  Eur J Health Econ       Date:  2011-10-11

Review 3.  Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics.

Authors:  Smith Etareri Evivie; Gui-Cheng Huo; John Oamen Igene; Xin Bian
Journal:  Food Nutr Res       Date:  2017-05-03       Impact factor: 3.894

4.  Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity.

Authors:  Bruce C M Wang; Edwin S Wong; Rafael Alfonso-Cristancho; Hao He; David R Flum; David E Arterburn; Louis P Garrison; Sean D Sullivan
Journal:  Eur J Health Econ       Date:  2013-03-24

5.  Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France, UK, US and Australia.

Authors:  Heinz Schneider; Eva S Dietrich; Werner P Venetz
Journal:  Int J Environ Res Public Health       Date:  2010-02-11       Impact factor: 3.390

6.  Bariatric surgery - can we afford to do it or deny doing it?

Authors:  Hutan Ashrafian; Ara Darzi; Thanos Athanasiou
Journal:  Frontline Gastroenterol       Date:  2011-04

7.  Impact of obesity on short-term results of laparoscopic rectal cancer resection.

Authors:  Thierry Bège; Bernard Lelong; Daniel Francon; Olivier Turrini; Jérome Guiramand; Jean-Robert Delpero
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

Review 8.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013

9.  Dietary supplementation of calcium may counteract obesity in mice mediated by changes in plasma fatty acids.

Authors:  Sarah Laraichi; Pilar Parra; Rocío Zamanillo; Ahmed El Amarti; Andreu Palou; Francisca Serra
Journal:  Lipids       Date:  2013-06-01       Impact factor: 1.880

10.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.